Airain Ltd’s Alaunos Therapeutics TCRT Stock Holding History

Airain Ltd’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-419	Closed	-$467K	–	888
2016 Q1	$467K	Buy	+419	New	+$429K	0.03%	457

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Airain Ltd's TCRT Position: Q2 2016 in Review

Airain Ltd sold out of Alaunos Therapeutics (TCRT) in Q2 2016, closing a stake of 419 shares — an estimated $467K sold.

Airain Ltd first reported a position in TCRT in Q1 2016 and held it in 1 quarter. The position peaked at $467K in Q1 2016. 154 funds tracked by Wall St. Rank hold TCRT as of Q2 2016.

Airain Ltd reported no remaining Alaunos Therapeutics position as of Q2 2016 after selling out during the quarter.
Airain Ltd sold 419 Alaunos Therapeutics shares in Q2 2016, an estimated $467K.
Airain Ltd first reported a position in Alaunos Therapeutics in Q1 2016 and held it in 1 quarter.
Airain Ltd's Alaunos Therapeutics position peaked at $467K in Q1 2016.
154 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2016.

Based on Airain Ltd's 13F filing for Q2 2016, filed 5 Aug 2016.